Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment

Thromb Haemost. 2006 Mar;95(3):576-8. doi: 10.1160/TH05-11-0746.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ear
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • IgA Vasculitis / drug therapy*
  • IgA Vasculitis / etiology
  • Ketanserin / therapeutic use
  • Male
  • Microcirculation / drug effects
  • Middle Aged
  • Nitroglycerin / therapeutic use
  • Pneumonia, Pneumococcal / complications
  • Recombinant Proteins / therapeutic use
  • Regional Blood Flow
  • Sepsis / complications
  • Skin / blood supply*
  • Skin / drug effects
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / therapeutic use*
  • Vasodilator Agents / therapeutic use

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Vasodilator Agents
  • Ketanserin
  • Tissue Plasminogen Activator
  • Nitroglycerin